Blood Transfusion Committees and Other Approaches to Improving Clinical Transfusion Practice

Abstract

In many countries, transfusion services now fall under the responsibility of national regulatory authorities concerned with the safety and efficacy of pharmaceutical products. As a result, many aspects of their work, especially those relating to the production of raw material plasma for fractionation, have been subject to regular inspection to ensure high standards of Quality Assurance (QA) and adherence to Good Manufacturing Practice (GMP). This regulation must be assumed to have made the products of the transfusion services both safer and better controlled in their adherence to nationally approved specifications such as the “Guidelines for blood transfusion services” in the United Kingdom [1].